Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oligodendroglial tumors.

Sajeel Chowdhary1, Marc C Chamberlain

  • 1H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33611, USA. chambemc@moffitt.usf.edu

Expert Review of Neurotherapeutics
|April 21, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Driven Telehealth Framework for Detecting Nystagmus.

Cureus·2025
Same author

A pilot survey into the landscape of neuro-oncology care in the community.

The oncologist·2025
Same author

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.

PloS one·2024
Same author

An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.

CNS oncology·2023
Same author

Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.

British journal of neurosurgery·2023
Same author

Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.

Neuro-oncology·2023
Same journal

Innovation is not enough: lessons from lasmiditan for real-world effectiveness in acute migraine therapy.

Expert review of neurotherapeutics·2026
Same journal

Can the integration of blood-based biomarkers into Alzheimer's disease diagnosis revolutionize the field?

Expert review of neurotherapeutics·2026
Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026
Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026
Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026
Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026
See all related articles

Oligodendroglial tumors, a type of glioma, are reviewed for classification and treatment. Recent trials offer evidence-based management strategies for these brain tumors.

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Neuropathology

Background:

  • Oligodendroglial tumors constitute 4-7% of gliomas, with incidence varying due to diagnostic advancements.
  • Classification includes low-grade, high-grade anaplastic, and mixed oligo-astrocytic tumors, each with distinct grades.

Purpose of the Study:

  • To provide a comprehensive overview of oligodendroglial tumors.
  • To discuss current and emerging treatment strategies based on recent evidence.

Main Methods:

  • Review of existing literature on oligodendroglial tumors.
  • Analysis of data from European Organization for Research and Treatment of Cancer and Radiation Therapy Oncology Group trials.

Main Results:

  • Established classification systems for oligodendroglial tumors.

Related Experiment Videos

  • Level 1 evidence from recent trials guiding treatment decisions.

    • Conclusions:

    • Improved histological and molecular understanding impacts oligodendroglial tumor incidence.
    • Contemporary treatment strategies are evolving, informed by robust clinical trial data.